Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ferlini

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Cytometry|February 19, 2000
Detection of apoptotic T lymphocytes in peripheral blood of human immunodeficiency virus (HIV)-infected subjects by apostainA Kunkl, M Paola Terranova, C Ferlini, et al.
Pharmacology & Toxicology|March 8, 2002
A new method to evaluate in vitro myelotoxicity of antitumour agents in the first steps of drug developmentC Ferlini, M Distefano, L Pierelli, et al.
Cancer Chemotherapy and Pharmacology|July 19, 2001
In vitro and in vivo antitumor activity of the novel trinuclear platinum complex BBR 3464 in neuroblastomaA Riccardi, D Meco, C Ferlini, et al.
The Prostate|September 6, 2001
Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cellsC Lanzi, G Cassinelli, G Cuccuru, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2001
The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatinT Servidei, C Ferlini, A Riccardi, et al.
Bioorganic & Medicinal Chemistry|September 8, 2000
Syntheses and biological activity of C-3'-difluoromethyl-taxoidsI Ojima, S Lin, J C Slater, et al.
British Journal of Cancer|December 6, 2000
Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitorsC Ferlini, M Distefano, F Pignatelli, et al.
Oncology Research|June 13, 2000
Cytotoxic effects toward human hematopoietic progenitor cells and tumor cell lines of paclitaxel, docetaxel, and newly developed analogues IDN5109, IDN5111, and IDN5127C Ferlini, M Distefano, L Pierelli, et al.
International Journal of Cancer|August 4, 1998
Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumorsG Ferrandina, G Almadori, N Maggiano, et al.
AIDS (London, England)|April 1, 1994
Lack of evidence for a superantigen in lymphocytes from HIV-discordant monozygotic twinsR Nisini, A Aiuti, P M Matricardi, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Cytometry|February 19, 2000
Detection of apoptotic T lymphocytes in peripheral blood of human immunodeficiency virus (HIV)-infected subjects by apostainA Kunkl, M Paola Terranova, C Ferlini, et al.
Pharmacology & Toxicology|March 8, 2002
A new method to evaluate in vitro myelotoxicity of antitumour agents in the first steps of drug developmentC Ferlini, M Distefano, L Pierelli, et al.
Cancer Chemotherapy and Pharmacology|July 19, 2001
In vitro and in vivo antitumor activity of the novel trinuclear platinum complex BBR 3464 in neuroblastomaA Riccardi, D Meco, C Ferlini, et al.
The Prostate|September 6, 2001
Cell cycle checkpoint efficiency and cellular response to paclitaxel in prostate cancer cellsC Lanzi, G Cassinelli, G Cuccuru, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2001
The novel trinuclear platinum complex BBR3464 induces a cellular response different from cisplatinT Servidei, C Ferlini, A Riccardi, et al.
Bioorganic & Medicinal Chemistry|September 8, 2000
Syntheses and biological activity of C-3'-difluoromethyl-taxoidsI Ojima, S Lin, J C Slater, et al.
British Journal of Cancer|December 6, 2000
Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitorsC Ferlini, M Distefano, F Pignatelli, et al.
Oncology Research|June 13, 2000
Cytotoxic effects toward human hematopoietic progenitor cells and tumor cell lines of paclitaxel, docetaxel, and newly developed analogues IDN5109, IDN5111, and IDN5127C Ferlini, M Distefano, L Pierelli, et al.
International Journal of Cancer|August 4, 1998
Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumorsG Ferrandina, G Almadori, N Maggiano, et al.
AIDS (London, England)|April 1, 1994
Lack of evidence for a superantigen in lymphocytes from HIV-discordant monozygotic twinsR Nisini, A Aiuti, P M Matricardi, et al.
Pageof 5